[[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-[[4-[(4-acetylpiperazin-1-yl)methyl]benzoyl]amino]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl]amino] formate

C42H55N5O10 — CID 89175098

IUPAC[[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-[[4-[(4-acetylpiperazin-1-yl)methyl]benzoyl]amino]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl]amino] formate
SMILESCO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NC(=O)c3ccc(CN4CCN(C(C)=O)CC4)cc3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1NOC=O)C2=O
InChIInChI=1S/C42H55N5O10/c1-25-19-32-38(44-42(54)31-13-11-30(12-14-31)23-46-15-17-47(18-16-46)29(5)49)34(50)22-33(40(32)52)43-41(53)26(2)9-8-10-35(55-6)37(45-57-24-48)27(3)21-28(4)39(51)36(20-25)56-7/h8-14,21-22,24-25,28,35-37,39,45,51H,15-20,23H2,1-7H3,(H,43,53)(H,44,54)/b10-8-,26-9+,27-21+/t25-,28+,35+,36+,37+,39-/m1/s1
InChIKeyLNGFPFLUKPQBDG-MYMMHQGQSA-N
MW789.93 g/mol
LogP2.44
Rot. Bonds9

About [[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-[[4-[(4-acetylpiperazin-1-yl)methyl]benzoyl]amino]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl]amino] formate

[[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-[[4-[(4-acetylpiperazin-1-yl)methyl]benzoyl]amino]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl]amino] formate (PubChem CID 89175098) has the molecular formula C42H55N5O10 and a molecular weight of 789.93 g/mol. Its IUPAC name is [[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-[[4-[(4-acetylpiperazin-1-yl)methyl]benzoyl]amino]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl]amino] formate.

Molecular Properties

Compound Name[[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-[[4-[(4-acetylpiperazin-1-yl)methyl]benzoyl]amino]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl]amino] formate
PubChem CID89175098
Molecular FormulaC42H55N5O10
Molecular Weight789.93 g/mol
Exact Mass789.39
IUPAC Name[[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-[[4-[(4-acetylpiperazin-1-yl)methyl]benzoyl]amino]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl]amino] formate
SMILESCO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NC(=O)c3ccc(CN4CCN(C(C)=O)CC4)cc3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1NOC=O)C2=O
InChIInChI=1S/C42H55N5O10/c1-25-19-32-38(44-42(54)31-13-11-30(12-14-31)23-46-15-17-47(18-16-46)29(5)49)34(50)22-33(40(32)52)43-41(53)26(2)9-8-10-35(55-6)37(45-57-24-48)27(3)21-28(4)39(51)36(20-25)56-7/h8-14,21-22,24-25,28,35-37,39,45,51H,15-20,23H2,1-7H3,(H,43,53)(H,44,54)/b10-8-,26-9+,27-21+/t25-,28+,35+,36+,37+,39-/m1/s1
InChIKeyLNGFPFLUKPQBDG-MYMMHQGQSA-N
XLogP2.44
TPSA192.91 Ų
H-Bond Donors4
H-Bond Acceptors12
Rotatable Bonds9
Heavy Atoms57
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500789.93
LogP ≤ 52.44
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'quinone_A(370)', 'substructure': 'N/A'}, {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'chinone_1', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze [[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-[[4-[(4-acetylpiperazin-1-yl)methyl]benzoyl]amino]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl]amino] formate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-[[4-[(4-acetylpiperazin-1-yl)methyl]benzoyl]amino]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl]amino] formate?
The IUPAC name of [[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-[[4-[(4-acetylpiperazin-1-yl)methyl]benzoyl]amino]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl]amino] formate (CID 89175098) is [[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-[[4-[(4-acetylpiperazin-1-yl)methyl]benzoyl]amino]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl]amino] formate.
What is the SMILES notation for [[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-[[4-[(4-acetylpiperazin-1-yl)methyl]benzoyl]amino]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl]amino] formate?
The canonical SMILES for [[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-[[4-[(4-acetylpiperazin-1-yl)methyl]benzoyl]amino]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl]amino] formate is CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NC(=O)c3ccc(CN4CCN(C(C)=O)CC4)cc3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1NOC=O)C2=O.
What is the InChIKey of [[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-[[4-[(4-acetylpiperazin-1-yl)methyl]benzoyl]amino]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl]amino] formate?
The InChIKey is LNGFPFLUKPQBDG-MYMMHQGQSA-N. The full InChI is InChI=1S/C42H55N5O10/c1-25-19-32-38(44-42(54)31-13-11-30(12-14-31)23-46-15-17-47(18-16-46)29(5)49)34(50)22-33(40(32)52)43-41(53)26(2)9-8-10-35(55-6)37(45-57-24-48)27(3)21-28(4)39(51)36(20-25)56-7/h8-14,21-22,24-25,28,35-37,39,45,51H,15-20,23H2,1-7H3,(H,43,53)(H,44,54)/b10-8-,26-9+,27-21+/t25-,28+,35+,36+,37+,39-/m1/s1.
What are the key properties of [[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-[[4-[(4-acetylpiperazin-1-yl)methyl]benzoyl]amino]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl]amino] formate?
[[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-[[4-[(4-acetylpiperazin-1-yl)methyl]benzoyl]amino]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl]amino] formate has a molecular weight of 789.93 g/mol, XLogP of 2.44, 9 rotatable bonds, 4 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for [[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-[[4-[(4-acetylpiperazin-1-yl)methyl]benzoyl]amino]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl]amino] formate is sourced from PubChem (CID 89175098), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).